A TGF-β signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response.
Wei-Wei DuanLi-Ting YangJian LiuZi-Yu DaiZe-Yu WangHao ZhangXun ZhangXi-Song LiangPeng LuoJian ZhangZao-Qu LiuNan ZhangHao-Yang MoChun-Run QuZhi-Wei XiaQuan ChenPublished in: CNS neuroscience & therapeutics (2023)
A prognostic lncRNA signature of TGF-β signaling was established in glioma, which can be used for prognostic judgment, immune infiltration status inference, and immunotherapy response prediction. AGAP2-AS1 plays an important role in glioma progression.